Hi-Tech Pharmacal Gains Approval for Ciprofloxacin Ophthalmic Solution

Hi-Tech Pharmacal has been granted FDA approval for its abbreviated new drug application (ANDA) for Ciprofloxacin Ophthalmic Solution USP, 0.3 percent.

Hi-Tech's Ciprofloxacin Ophthalmic Solution USP, 0.3 percent is the generic equivalent of Alcon Laboratories' Ciloxan Ophthalmic Solution, 0.3 percent indicated for the treatment of bacterial infections. The company expects to start marketing its Ciprofloxacin Ophthalmic Solution USP, 0.3 percent in February.